RenovaCare gets FDA IDE approval to begin SkinGun and CellMist system trial
The trial will assess the safety and feasibility of the system to treat burn wounds
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
The trial will assess the safety and feasibility of the system to treat burn wounds
The company will recruit up to 100 patients at 10 US sites in the multicentre prospective comparative study
The lung-on-a-chip platform will be examined for inhaled drug evaluation applications
aPROMISE will help conduct quantitative assessment of prostate-specific membrane antigen PET/CT in oncology
The partnership is expected to offer a faster route to market Avacta’s rapid antigen test
The sensor technology will help the company to initially develop a rapid point-of-care Covid-19 test
The application is developed to offer accurate diagnostic information without exposing patients to high doses of radiation and…
The VS Series is designed to deliver vital sign measurements at rapid speeds to maximise patient comfort and…
GE Healthcare Life Sciences helps therapy innovators, researchers and healthcare providers to invent, manufacture and use precision diagnostics…
The RightEye Vision System has secures FDA approval for recording, viewing, and analysing eye movements to identify visual…